<?xml version="1.0" encoding="UTF-8"?>
<p>Methylglyoxal is the metabolite whose concentration increases in the blood during diabetes and causes atherogenesis (a condition where artheromatous plaque develop in arteries, with blockage problems) and it also attaches with nerve ending resulting in nerve damage [
 <xref rid="B91-molecules-25-05243" ref-type="bibr">91</xref>]. Clinical trials on quercetin indicated a decrease in the plasma level of methylglyoxal while epicatechin has no promising effect. This showed the different potency of various flavonoids against specific disease.
</p>
